Danske Bank’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,000
Closed -$305K 1305
2025
Q4
$305K Hold
3,000
﹤0.01% 650
2025
Q3
$164K Buy
3,000
+1,800
+150% +$89.9K ﹤0.01% 805
2025
Q2
$63.8K Sell
1,200
-74,359
-98% -$3.78M ﹤0.01% 966
2025
Q1
$3.27M Sell
75,559
-4,200
-5% -$213K 0.01% 588
2024
Q4
$4.48M Buy
79,759
+15,800
+25% +$983K 0.01% 556
2024
Q3
$4.36M Buy
63,959
+3,000
+5% +$169K 0.01% 564
2024
Q2
$2.58M Sell
60,959
-48,011
-44% -$2.64M 0.01% 610
2024
Q1
$7.53M Buy
+108,970
New +$6.89M 0.02% 488

Other funds holding EXAS

Danske Bank's EXAS Position: Q1 2026 in Review

Danske Bank sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,000 shares — an estimated $305K sold.

Danske Bank first reported a position in EXAS in Q1 2024 and held it in 8 quarters. The position peaked at $7.53M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Danske Bank reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 3,000 Exact Sciences shares in Q1 2026, an estimated $305K.
  • Danske Bank first reported a position in Exact Sciences in Q1 2024 and held it in 8 quarters.
  • Danske Bank's Exact Sciences position peaked at $7.53M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.